Proton beam therapy specialist Advanced Oncotherapy (AVO) has announced a £6m equity fundraise to support its operations following news that it expects to treat the first patient with its next generation LIGHT system in the second half of next year. The fundraise has been conducted through a direct subscription for a total of 24,000,000 new ordinary shares of…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2024 All rights reserved LaingBuisson 
 has announced a £6m equity fundraise to support its operations following news that it expects to treat the first patient with its next generation LIGHT system in the second half of next year.){kind=link}